The world's first malaria vaccine (Mosquirix) has received a green light for future use in babies in sub-Saharan Africa, which is backed by Bill Gates. The European Medicines Agency gave the Mosquirix vaccine a favorable review after 30 years of research by GlaxoSmithKline and the PATH Malaria Vaccine Initiative.